At the recent 2024 PQA Annul Meeting, Stephen Jones, VP Advanced Analytics, joined Sheila Botts, Regional Administrator, Clinical Pharmacy Services at Kaiser Permanente, Colorado and Vanessa Campbell, Director, Clinical Pharmacy at UPMC Health Plan to talk about unfavorable social-risk factors (SRF) and how they negatively impact medication adherence and health outcomes. Working with our payer partners, RxAnte developed a supervised machine learning model to identify at-risk SRF cohorts. Tailored outreach was developed by our clients to identify and address barriers to medication adherence and other health behaviors. Attendees learned the impact of SRF on medication adherence and how to develop actionable outreach programs that can deliver better care to at-risk patients. To learn more about RxAnte’s SRF Queue, visit https://hubs.li/Q02Cln3z0
RxAnte’s Post
More Relevant Posts
-
Click the link to read the exciting news release on EurekAlert of AAAS of our latest study with UPMC Health Plan! 📰 https://hubs.li/Q02ns9JR0 Our research on pharmacy care management services for medically complex Medicare Advantage members shows remarkable outcomes: reduced care costs, fewer inpatient stays, and improved medication adherence. Discover how personalized care can make a significant difference in healthcare outcomes. 🏥💊 #HealthcareInnovation #MedicareAdvantage #PharmacyCare
-
Watch the incredible passion that the team of Mosaic Pharmacy Service has to offer! Mosaic operates with a team of incredible individuals that help the lives of patients everyday with top-notch clinical care. Please join us in celebrating Mosaic Pharmacy Service. 💊 Be Part of Mosaic's Success: https://lnkd.in/gvG5am5y #Mosaic #pharmacy #valuebasedcare #hiring #workculture #patientfirst
Meet our incredible colleagues of Mosaic Pharmacy Service who represent the pride of our unique work culture! Join us on an incredible pharmacy journey where every day is an opportunity to make a meaningful impact on the lives of our patients. We are a team dedicated to providing top-notch clinical care while fostering collaboration, innovation, and inclusion. Watch the video now and be a part of the Mosaic experience. 💊 Visit our careers page: https://lnkd.in/gvG5am5y #Mosaic #Pharmacy #PatientFirst #Hiring #WorkCulture
-
Exciting news! We are pleased to share our 12-month Mosaic outcomes study in NEJM Catalyst Innovations in Care Delivery! Read the key takeaways below. What are your thoughts and insight? #WhitePaper #IndustryInsights #Knowledgesharing
Medicare Advantage programs have grown rapidly, and a shift toward more medically complex beneficiaries has implications for health care utilization, costs, and quality in the MA program. Ensuring safe and effective medication use in this population has been identified as a priority, yet there is limited evidence to guide MA plans’ pharmacy care management efforts. The goal of this study was to investigate the impact of an integrated PCM program for MA beneficiaries taking multiple chronic medications, including a subset with high predicted cost savings from improved medication adherence, assessed using the Value of Future Adherence score. Using adjudicated administrative claims data from a regional Medicare Advantage and Part D plan, a retrospective matched cohort study was designed. PCM program enrollees underwent monthly medication reviews, reconciliation, and synchronization of refills, which were dispensed and delivered to the home in adherence packaging by a specially equipped pharmacy. Members were contacted monthly and received, as needed, education, referral to health care providers, consultation with prescribers on changes to medication regimens, and referral to social support or case management programs. Primary outcomes of interest were per enrollee per month costs, resource utilization, and medication adherence for three MAPD Star Ratings measures over 12 months for all members and for the subgroup with a high VFA score. Among all PCM program enrollees, there was a PEPM increase in average pharmacy spending compared with control members and an offsetting decrease in medical spending, resulting in PCM participants having lower total cost of care, fewer inpatient stays, and improvements in medication adherence. These findings support the potential value of an integrated PCM program for MAPD beneficiaries on multiple medications, particularly when targeted to those members predicted to benefit most: https://nej.md/48Q9VQ9
-
-
We are so excited to have Nancy Cocozza join RxAnte's Board of Directors! Ms. Cocozza is a former senior vice president of CVS Aetna and a renowned industry veteran with over 30 years of experience. Her experience will bring crucial value to our RxAnte clients as we continue to pioneer our value-based pharmacy care management services. "I'm excited to work with a board that is so passionate about getting medications to patients in the most efficient and effective ways possible," Cocozza said. "Improving prescription drug use is a $528 billion per year cost savings opportunity, and few have the dedication and the capacity to make a difference in patients' lives quite like the team at RxAnte." Read the full article below: https://hubs.li/Q01Z-d5f0 https://hubs.li/Q01Z-dDK0
Nancy Cocozza Joins RxAnte Board of Directors
prnewswire.com
-
The Centers for Medicare and Medicaid have ahead of them the goal of getting 100% of Medicare (and the majority of Medicaid) beneficiaries to be enrolled in some type of accountable, or value-based, care arrangement by 2030. At the heart of these arrangements are patient outcomes which can only be measured if organizations have access to comprehensieve and efficient patient data. However, three barriers – takeholders speak different data languages; data isn’t mapped consistently; and data isn’t interpreted congruently between providers and payers – are keeping us from interoperability. Health Data Management put together a great piece on how we can achieve data standardization, specifically for quality measures.
-
Medication costs continue to be high. Experts are expecting the cost of treatment to continue to go up for the next year. The four main influences driving these cost trends are inflation, reimbursement rates, pharmaceutical pricing and consolidation. To mitigate these costs, consumers can research value-based care models and look into biosimilar coverage. Learn more here: https://hubs.li/Q01XGlXk0
4 Key Inflators That Are Fueling Medical Cost Trends, Pricing
healthpayerintelligence.com
